A2780

Version 4.0.200811

This is the complete description of the cell line that you requested. By selecting a generic term (e.g. SPECIES) you will go to the corresponding list of controlled terms, while by selecting a specific term you will go to the list of corresponding cell line names.

A2780 (human, ovary, carcinoma)

SPECIES: human
TISSUE/ORGAN: ovary
TUMOR: carcinoma

ECACC catalog code: 93112519
Morphology: Epithelial
Description: Human ovarian carcinoma
Viruses: See Properties
Depositor: Dr T H Ward, Cell Culture Unit, Patterson Laboratories, Christie Hospital, Manchester, UK (Originator)
No restrictions. Patent: None Specified By Depositor
Properties: Applications: Toxicity testing, cancer genetic studies.

Available in the following LABORATORY:

Part of the Business Division of the Health Protection Agency (ECACC, Salisbury, Wiltshire)
RPMI 1640 + 2mM Glutamine + 10% Fetal Bovine Serum (FBS). Split confluent cultures 1:3 to 1:6 i.e. seeding at 3-6x10,000cells/cm² using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37C.
The A2780 human ovarian cancer cell line was established from tumour tissue from an untreated patient. Cells grow as monolayer and in suspension in spinner cultures. A2780 is the parent line to the cisplatin resistant cell line A2780 cis (ECACC No. 93112517) and the adriamycin resistant cell line A2780 ADR (ECACC No. 93112520).
Research council deposit: No; Price Code: C;
Validated by: isoenzymes (species confirmation)

Availability in cell line catalogues: ICLC: HTL98008

Bibliographic references:

Cancer Res 1987;47:414 - PMID: 3539322
Semin Oncol 1984;11:285 - PMID: 6385258